Simposi
Translational Strategy For Assessing New Mechanisms For The Development Of Innovative Therapeutic Approach In Psychiatric Disorders
26 ottobre 2017 / 8.30-10.30
| 58 |
Role of the endocannabinoid system in spatial learning Carsten T. Wotjak (Munich - Germany) |
| 59 |
Vesicular glutamate transporter as circuit-based therapeutic target for depression: evidence from a gender-oriented animal mode Anna Brancato (Palermo) |
| 60 |
A precision medicine genetic marker for core cognitive deficits in schizophrenia Francesco Papaleo (Genoa) |
| 61 |
The Neurosteroidogenic Enzyme 5?-Reductase Mediates Psychotic-Like Complications of Sleep Deprivation Roberto Frau (Cagliari) |
| 62 |
Early modulation of the endocannabinoid tone prevents the onset of a schizophrenia-like phenotype Tibor Stark (Brno-Czech Republic) |
| 63 |
Epigenetic regulation of CNR1 gene in schizophrenia Claudio D’Addario (Teramo) |
| 64 |
From single synapses to clinical studies. Therapeutic developments from optogenetics Antonello Bonci (Baltimore - USA) |